2015
DOI: 10.1002/stem.1947
|View full text |Cite
|
Sign up to set email alerts
|

miR-223 Regulates Adipogenic and Osteogenic Differentiation of Mesenchymal Stem Cells Through a C/EBPs/miR-223/FGFR2 Regulatory Feedback Loop

Abstract: Several miRNAs have recently been identified to regulate adipocyte or osteoblast differentiation or both. In this study, miR-223 was found to be involved in the reciprocal regulation of adipocyte and osteoblast differentiation. miR-223 was induced in primary cultured mouse marrow stromal cell, mesenchymal line C3H10T1/2 and stromal line ST2 after adipogenic treatment. Conversely, it was reduced in preosteoblast MC3T3-E1 after osteogenic treatment. Supplementing miR-223 levels using synthetic miR-223 mimics sig… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

8
80
1
1

Year Published

2015
2015
2020
2020

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 78 publications
(90 citation statements)
references
References 50 publications
(55 reference statements)
8
80
1
1
Order By: Relevance
“…Specifically, several basal miRNAs (miR-125b, miR-142, miR-143, miR-152, miR-155, and miR-221/222/223) have been predicted to block genes in the adipogenesis and RXR activation pathways [21-23]. Most notably, miR-125b, miR-223, miR-99a, and miR-212 target FGFR2 and FGFR3, which are involved in luminal MIBC biology [5, 22, 24, 25]. Several basal miRNAs (miR-125b, miR-142, miR-152, miR-146b, miR-222, and miR-212) have also been predicted to target luminal factors that have been previously identified in breast cancer, including ERBB2, ERBB3, ERBB4, and FOXA1 [26-28].…”
Section: Resultsmentioning
confidence: 99%
“…Specifically, several basal miRNAs (miR-125b, miR-142, miR-143, miR-152, miR-155, and miR-221/222/223) have been predicted to block genes in the adipogenesis and RXR activation pathways [21-23]. Most notably, miR-125b, miR-223, miR-99a, and miR-212 target FGFR2 and FGFR3, which are involved in luminal MIBC biology [5, 22, 24, 25]. Several basal miRNAs (miR-125b, miR-142, miR-152, miR-146b, miR-222, and miR-212) have also been predicted to target luminal factors that have been previously identified in breast cancer, including ERBB2, ERBB3, ERBB4, and FOXA1 [26-28].…”
Section: Resultsmentioning
confidence: 99%
“…An increasing amount of microRNAs has been demonstrated as regulators of different aspects of bone development or osteoblast differentiation. Some of them have been reported as inhibitors of osteogenic differentiation such as miR-34a [39] or miR-223 [40] in human stromal cells. As our results expose, the effect of these microRNAs is the same in human AF-MS cells as their levels significantly decreased after osteogenic differentiation induction.…”
Section: Discussionmentioning
confidence: 99%
“…In the present study, we further found that DHRS3 can promote osteogenic differentiation in vitro. Recent reports have demonstrated regulatory roles for miR-223 in bone metabolism, including in mediating the repression of the key proteins required for osteoblast differentiation [29]. For instance, miR-223 downregulates osteoblast differentiation through a C/EBPα/miR-223/FGFR2 regulatory feedback loop [29].…”
Section: Cellular Physiology and Biochemistrymentioning
confidence: 99%
“…Recent reports have demonstrated regulatory roles for miR-223 in bone metabolism, including in mediating the repression of the key proteins required for osteoblast differentiation [29]. For instance, miR-223 downregulates osteoblast differentiation through a C/EBPα/miR-223/FGFR2 regulatory feedback loop [29]. To maintain physiological bone metabolism, osteoblasts and osteoclasts coordinate with each other and maintain the balance between bone formation and resorption, which is always determined by the differentiation of osteoblasts and osteoclasts [30].…”
Section: Cellular Physiology and Biochemistrymentioning
confidence: 99%